Skip to main content

Table 4 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-C30 scores of patients with chronic obstructive pulmonary disease (COPD) according to airway obstruction

From: Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer

Variables

GOLD grade 1

(n = 35)

GOLD grade 2

(n = 103)

GOLD grade 3

(n = 24)

GOLD grade 4

(n = 8)

p value

Global health status/QoL

50.5 ± 26.3

50.2 ± 23.0

41.0 ± 19.0

30.2 ± 26.7

0.049

Functional scales

 Physical functioning

83.4 ± 17.1

75.4 ± 22.7

66.7 ± 24.4

53.3 ± 30.4

0.004

 Role functioning

79.5 ± 31.3

75.9 ± 24.2

69.4 ± 33.9

54.2 ± 39.6

0.132

 Emotional functioning

75.0 ± 26.2

76.4 ± 25.0

78.5 ± 21.8

70.8 ± 32.1

0.970

 Cognitive functioning

87.1 ± 21.4

79.0 ± 25.1

77.8 ± 22.3

75.0 ± 21.8

0.123

 Social functioning

72.4 ± 28.9

68.1 ± 26.4

68.1 ± 26.4

60.4 ± 33.3

0.646

Symptom scales/items

 Fatigue

25.1 ± 24.6

34.5 ± 22.8

40.7 ± 24.7

47.2 ± 31.3

0.011

 Nausea and vomiting

9.5 ± 23.3

9.2 ± 15.8

1.4 ± 4.7

8.3 ± 23.6

0.059

 Pain

18.6 ± 30.2

22.0 ± 26.8

20.1 ± 26.5

25.0 ± 38.8

0.622

 Dyspnea

20.0 ± 24.5

33.7 ± 31.8

44.4 ± 36.3

54.2 ± 35.4

0.010

 Insomnia

24.8 ± 31.7

27.2 ± 29.4

36.1 ± 31.0

37.5 ± 37.5

0.352

 Appetite loss

27.6 ± 36.6

30.4 ± 32.0

31.9 ± 36.1

45.8 ± 43.4

0.621

 Constipation

14.3 ± 24.6

16.2 ± 26.8

19.4 ± 31.0

41.7 ± 49.6

0.435

 Diarrhea

7.6 ± 18.2

7.8 ± 20.5

6.9 ± 17.0

4.2 ± 11.8

0.988

 Financial difficulties

25.7 ± 31.4

32.7 ± 29.9

40.3 ± 34.0

37.5 ± 33.0

0.320

  1. Data are mean (±SD). GOLD Global Initiative for Chronic Obstructive Lung Disease, QoL quality of life
  2. ANOVA test was used